Clearstead Advisors, LLC Danaher Corp Transaction History

Clearstead Advisors, LLC

$6.31 Billion
Q3 2024

A detailed history of Clearstead Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Clearstead Advisors, LLC holds 87,401 shares of DHR stock, worth $20.2 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

87,401

Previous 87,419 0.02%

Holding current value

$20.2 Million

Previous $21.8 Million 11.24%

% of portfolio

0.39%

Previous 0.38%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$239.25 - $280.76 $4,306 - $5,053	-18 Reduced 0.02%	87,401 $24.3 Million
Q2 2024 Aug 09, 2024	BUY	$235.51 - $267.98 $15.9 Million - $18.1 Million	67,467 Added 338.15%	87,419 $21.8 Million
Q1 2024 May 14, 2024	BUY	$224.58 - $256.19 $82,196 - $93,765	366 Added 1.87%	19,952 $4.98 Million
Q4 2023 Feb 12, 2024	BUY	$185.1 - $233.13 $21,841 - $27,509	118 Added 0.61%	19,586 $4.53 Million
Q3 2023 Nov 13, 2023	SELL	$233.08 - $265.59 $768,464 - $875,650	-3,297 Reduced 14.48%	19,468 $4.83 Million
Q3 2023 Nov 07, 2023	BUY	$233.08 - $265.59 $955,161 - $1.09 Million	4,098 Added 21.95%	22,765 $5.65 Million
Q2 2023 Aug 07, 2023	BUY	$224.99 - $256.14 $768,340 - $874,718	3,415 Added 22.39%	18,667 $4.48 Million
Q1 2023 May 09, 2023	BUY	$239.75 - $277.0 $541,595 - $625,743	2,259 Added 17.39%	15,252 $3.84 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $40,075 - $46,860	166 Added 1.29%	12,993 $3.45 Million
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $603,567 - $3.68 Million	-2,443 Reduced 16.0%	12,827 $3.31 Million
Q2 2022 Aug 12, 2022	BUY	$237.11 - $299.66 $241,140 - $304,754	1,017 Added 7.14%	15,270 $3.87 Million
Q1 2022 May 04, 2022	BUY	$257.27 - $315.76 $122,460 - $150,301	476 Added 3.46%	14,253 $4.18 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $299,674 - $337,564	1,026 Added 8.05%	13,777 $4.53 Million
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $285,548 - $348,719	-1,049 Reduced 7.6%	12,751 $3.88 Million
Q2 2021 Aug 12, 2021	SELL	$225.08 - $271.69 $15,080 - $18,203	-67 Reduced 0.48%	13,800 $3.7 Million
Q1 2021 May 14, 2021	BUY	$212.38 - $245.9 $115,959 - $134,261	546 Added 4.1%	13,867 $3.12 Million
Q4 2020 Feb 11, 2021	BUY	$212.5 - $245.46 $607,325 - $701,524	2,858 Added 27.32%	13,321 $2.96 Million
Q3 2020 Nov 12, 2020	BUY	$177.16 - $215.33 $4,429 - $5,383	25 Added 0.24%	10,463 $2.25 Million
Q2 2020 Aug 11, 2020	SELL	$128.7 - $176.83 $31,145 - $42,792	-242 Reduced 2.27%	10,438 $1.85 Million
Q1 2020 May 14, 2020	SELL	$121.39 - $169.05 $122,603 - $170,740	-1,010 Reduced 8.64%	10,680 $1.48 Million
Q4 2019 Feb 11, 2020	BUY	$133.47 - $153.48 $155,759 - $179,111	1,167 Added 11.09%	11,690 $1.79 Million
Q3 2019 Nov 12, 2019	SELL	$135.4 - $146.47 $77,313 - $83,634	-571 Reduced 5.15%	10,523 $1.52 Million
Q2 2019 Aug 08, 2019	BUY	$124.88 - $143.73 $8,741 - $10,061	70 Added 0.63%	11,094 $1.59 Million
Q1 2019 May 14, 2019	SELL	$97.62 - $132.29 $32,116 - $43,523	-329 Reduced 2.9%	11,024 $1.46 Million
Q4 2018 Feb 11, 2019	SELL	$94.85 - $109.54 $15,839 - $18,293	-167 Reduced 1.45%	11,353 $1.17 Million
Q3 2018 Nov 13, 2018	SELL	$98.13 - $108.9 $2,453 - $2,722	-25 Reduced 0.22%	11,520 $1.25 Million
Q2 2018 Aug 07, 2018	BUY	$96.1 - $103.24 $28,541 - $30,662	297 Added 2.64%	11,545 $1.14 Million
Q1 2018 May 14, 2018	BUY	$92.16 - $103.8 $2,672 - $3,010	29 Added 0.26%	11,248 $1.1 Million
Q4 2017 Feb 09, 2018	BUY	$85.26 - $94.62 $30,267 - $33,590	355 Added 3.27%	11,219 $1.04 Million
Q3 2017 Nov 09, 2017	BUY	$79.29 - $88.45 $861,406 - $960,920	10,864	10,864 $932,000

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Danaher Corp Transaction History